Partridge Andrew John 4
4 · Turning Point Therapeutics, Inc. · Filed Jul 15, 2021
Insider Transaction Report
Form 4
Partridge Andrew John
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-07-14$74.90/sh−1,869$139,988→ 21,767 total
Footnotes (1)
- [F1]Sale of shares of common stock to cover tax withholding obligations associated with vesting of a restricted stock unit award granted to Reporting Person on July 13, 2020.